Apriori Bio Receives $1.1M Funding from CEPI to Advance AI Platform for Virus Protection

Apriori Bio, a pioneering biotechnology firm, has secured a significant funding injection of US $1.1 million from CEPI (Coalition for Epidemic Preparedness Innovations) to propel its cutting-edge artificial intelligence platform, Octavia™. Designed to safeguard against rapidly-evolving viral threats, Octavia™ employs advanced machine learning to predict and counteract virus mutations, crucial for developing variant-resilient vaccines. Octavia™…

Read More

Certify Locks in $40M to Lead the Future of Provider Data Intelligence in Healthcare

Certify, a pioneer in provider data intelligence, has secured $40 million in a Series B funding round led by Transformation Capital, with continued investment from General Catalyst, Upfront Ventures, and new funding from SemperVirens. This infusion brings Certify’s total capital raised to $69 million and follows a remarkable triple-year growth trajectory. Founded and led by…

Read More

NanoSyrinx Secures £10M to Propel Revolutionary Nano Syringe Delivery Platform

In a significant boost to the biotech sector, NanoSyrinx, a trailblazer in targeted intracellular delivery technologies, has successfully completed a £10 million financing round. This pivotal investment will accelerate the development of NanoSyrinx’s cutting-edge nano syringe platform, designed to enhance the precision of biologic therapeutic delivery. NanoSyrinx’s innovative approach leverages naturally occurring ‘nano syringes’—microscopic delivery…

Read More
BBTruck_CEO

BBTruck Secures $6.5 Million in Pre-Series A Funding to Propel Global Growth and Innovation

BBTruck, a vanguard in supply chain and logistics technology, has successfully completed a pre-Series A funding round, raising an impressive $6.5 million. This latest round, led by prominent investors Oasis Venture, H2U Corp., and StarWorks Entrepreneurial Venture Capital, marks a significant milestone in BBTruck’s journey toward global expansion and technological advancement. With this influx of…

Read More

ReliON Charges Up with $3 Million Investment to Bolster EV Charging Reliability

Canadian cleantech innovator ReliON has secured a critical investment of $3 million CAD to propel its mission of ensuring seamless operation within the electric vehicle (EV) charging infrastructure landscape. The funding round, led by Diagram Ventures with participation from MaRS IAF, AQC Capital, Anges Québec, and Cycle Momentum, empowers ReliON to solidify its position as…

Read More

Tolerance Bio, Inc. Secures $17.2 Million Seed Financing to Revolutionize Thymus-Based Therapies for Immune Disorders

In a significant development for the biopharmaceutical landscape, Tolerance Bio, Inc. has announced the successful closure of its oversubscribed $17.2 million seed financing round. Spearheaded by Columbus Venture Partners, this funding will accelerate the company’s innovative work on thymus preservation, regeneration, and manipulation therapies aimed at treating a range of immune-mediated diseases. Founded by industry…

Read More

Palm Secures $6.1M in Seed Funding to Revolutionize Enterprise Cash Management

Fintech startup Palm has announced a successful Seed funding round, raising $6.1 million to enhance enterprise cash management. This innovative platform aims to transform the way treasury teams manage cash flow across multiple bank accounts and subsidiaries globally. Palm’s solution delivers a comprehensive overview of both historical and projected cash flows, serving as a central…

Read More

Yeti Confetti™ Kids App by Lirvana Labs Empowers Children with AI-Powered Learning, Achieving Significant Educational Milestones

Lirvana Labs, the innovative force behind the Yeti Confetti™ Kids app, announces remarkable advancements in childhood education with its AI-driven learning platform. Recent data reveals that just 15 minutes of weekly engagement on the app can boost English literacy and mathematical reasoning skills by half a grade level in a mere 10 weeks, underscoring its…

Read More

AI Injects Precision into Pharma Manufacturing: Modicus Prime Secures $3.5 Million

Good news for the pharmaceutical industry! Modicus Prime, a Texas-based innovator, has secured $3.5 million in Series A funding to revolutionize drug manufacturing with their AI-powered quality control solution, mpVision. This investment, led by Silverton Partners, empowers Modicus Prime to tackle a persistent challenge – ensuring consistent quality and eliminating costly errors during production. Traditionally,…

Read More